Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divalent cation chelation, in the context of biofilm disruption, refers to the process of binding and sequestering divalent metal ions—such as calcium (Ca²⁺), magnesium (Mg²⁺), manganese (Mn²⁺), and zinc (Zn²⁺)—using molecules known as chelators. This process targets the structural integrity of bacterial biofilms by removing essential metal ions that stabilize components of the extracellular matrix (ECM). Chelators like EDTA or EGTA bind divalent cations with high affinity, breaking ionic bridges between matrix polymers and resulting in loss of cohesion within the biofilm matrix and increased susceptibility to antimicrobial agents. This strategy is non-specific but effective across diverse bacterial species due to universal reliance on divalent cations in ECM architecture.
Sequestration of divalent cations (Ca2+, Mg2+, Mn2+, Zn2+) from the biofilm extracellular matrix, disrupting its structural integrity and promoting dispersal.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Divalent Cation Chelation (Biofilm Disruption).